Correlation Between MedTech Acquisition and Tastemaker Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MedTech Acquisition and Tastemaker Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MedTech Acquisition and Tastemaker Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MedTech Acquisition and Tastemaker Acquisition Corp, you can compare the effects of market volatilities on MedTech Acquisition and Tastemaker Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MedTech Acquisition with a short position of Tastemaker Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of MedTech Acquisition and Tastemaker Acquisition.

Diversification Opportunities for MedTech Acquisition and Tastemaker Acquisition

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between MedTech and Tastemaker is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding MedTech Acquisition and Tastemaker Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tastemaker Acquisition and MedTech Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MedTech Acquisition are associated (or correlated) with Tastemaker Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tastemaker Acquisition has no effect on the direction of MedTech Acquisition i.e., MedTech Acquisition and Tastemaker Acquisition go up and down completely randomly.

Pair Corralation between MedTech Acquisition and Tastemaker Acquisition

If you would invest  6.20  in Tastemaker Acquisition Corp on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Tastemaker Acquisition Corp or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MedTech Acquisition  vs.  Tastemaker Acquisition Corp

 Performance 
       Timeline  
MedTech Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MedTech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental indicators, MedTech Acquisition is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Tastemaker Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tastemaker Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Tastemaker Acquisition is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

MedTech Acquisition and Tastemaker Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MedTech Acquisition and Tastemaker Acquisition

The main advantage of trading using opposite MedTech Acquisition and Tastemaker Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MedTech Acquisition position performs unexpectedly, Tastemaker Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tastemaker Acquisition will offset losses from the drop in Tastemaker Acquisition's long position.
The idea behind MedTech Acquisition and Tastemaker Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope